Kodchanan Singhanat
Bangkok, 10700, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Prognostic and therapeutic importance of TROP-2 and MUC-1 in non-small cell lung cancer: A systematic review and meta-analysis.
Journal: Biomedical reports
Published: April 14, 2026
Identification of Tumor Budding-Associated Genes in Breast Cancer through Transcriptomic Profiling and Network Diffusion Analysis.
Journal: Biomolecules
Published: June 25, 2024
Acute administration of myeloid differentiation factor 2 inhibitor and N-acetyl cysteine attenuate brain damage in rats with cardiac ischemia/reperfusion injury.
Journal: Archives of biochemistry and biophysics
Published: October 20, 2022
Therapeutic potential of a single-dose melatonin in the attenuation of cardiac ischemia/reperfusion injury in prediabetic obese rats.
Journal: Cellular and molecular life sciences : CMLS
Published: January 25, 2022
The temporal impact of erythropoietin administration on mitochondrial function and dynamics in cardiac ischemia/reperfusion injury.
Journal: Experimental and molecular pathology
Published: January 03, 2022
Erythropoietin administration exerted neuroprotective effects against cardiac ischemia/reperfusion injury.
Journal: Current research in pharmacology and drug discovery
Published: November 24, 2021
An apoptosis inhibitor suppresses microglial and astrocytic activation after cardiac ischemia/reperfusion injury.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: October 02, 2021
Inhibition of myeloid differentiation factor 2 attenuates cardiometabolic impairments via reducing cardiac mitochondrial dysfunction, inflammation, apoptosis and ferroptosis in prediabetic rats.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: July 05, 2021
Necrostatin-1 reduces cardiac and mitochondrial dysfunction in prediabetic rats.
Journal: The Journal of endocrinology
Published: June 07, 2021
Cell death inhibitors protect against brain damage caused by cardiac ischemia/reperfusion injury.
Journal: Cell death discovery
Published: May 11, 2021
Melatonin as a therapy in cardiac ischemia-reperfusion injury: Potential mechanisms by which MT2 activation mediates cardioprotection.
Journal: Journal of advanced research
Published: May 20, 2020
Roles of melatonin and its receptors in cardiac ischemia-reperfusion injury.
Journal: Cellular and molecular life sciences : CMLS
Published: May 31, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026